Garlic (Allium sativum) has been valued for centuries as both a food and a traditional remedy. Today, researchers are studying garlic and other members of the Allium genus, including onions, leeks and shallots, for their potential role in cancer prevention. Particular interest has focused on cancers of the digestive system, especially stomach and colorectal cancers. Although laboratory research is promising, evidence from human studies remains mixed, so garlic should be regarded as a potentially beneficial food rather than a cancer treatment.
One reason garlic attracts scientific attention is its rich supply of sulfur-containing compounds. When garlic is crushed, chopped or chewed, the enzyme alliinase converts alliin into allicin. Allicin is unstable and rapidly produces other organosulfur compounds, including diallyl sulfide, diallyl disulfide, diallyl trisulfide and S-allylcysteine. Laboratory and animal studies suggest that these compounds can influence several biological processes associated with cancer development.
One important mechanism is apoptosis, or programmed cell death. Research in experimental models indicates that garlic compounds can activate pathways that cause abnormal cells to die rather than continue multiplying. They may also interfere with cell-cycle regulation, potentially slowing the proliferation of cancer cells. Other experiments suggest that some garlic-derived compounds can inhibit angiogenesis, the formation of new blood vessels that tumors need for continued growth. Garlic compounds may additionally influence antioxidant defenses and enzymes involved in the metabolism of potentially carcinogenic substances.
The digestive tract has received particular attention because garlic compounds and their metabolites interact directly with tissues exposed to food. Epidemiological research has reported associations between greater garlic consumption and lower risks of stomach and colorectal cancer. A 2022 systematic review and meta-analysis reported inverse associations for both gastric and colorectal cancer, although the authors emphasized that the biological mechanisms and strength of the evidence require further investigation.
Stomach cancer is especially interesting because infection with Helicobacter pylori (H. pylori) is an established risk factor. Garlic has antimicrobial activity in laboratory experiments, leading researchers to investigate whether it can influence H. pylori. However, human evidence has not consistently demonstrated that eating garlic eliminates or prevents H. pylori infection. A systematic review found that most included studies did not show a significant relationship, and many had methodological limitations. Importantly, proven H. pylori eradication treatment has substantially stronger evidence for reducing gastric-cancer risk than garlic consumption.
For colorectal cancer, experimental studies provide plausible mechanisms, while human observational research has produced less consistent results. One systematic review of clinical and cohort studies concluded that the available evidence was insufficient to establish a firm protective effect. Differences in diet, garlic preparation, quantity consumed and study design can all influence findings.
Overall, garlic is a nutritious addition to a varied diet and contains biologically active compounds with intriguing anticancer properties. However, there is currently no strong evidence that garlic alone can prevent or treat cancer. Eating garlic alongside vegetables, fruits, whole grains and other nutritious foods is a sensible approach to healthy eating, while proven cancer screening, medical advice and appropriate treatments remain essential.
The Anticancer Properties of Garlic: Mechanisms and Digestive Health Benefits
